Gloria Galimberti

650 total citations
15 papers, 507 citations indexed

About

Gloria Galimberti is a scholar working on Molecular Biology, Physiology and Rheumatology. According to data from OpenAlex, Gloria Galimberti has authored 15 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Rheumatology. Recurrent topics in Gloria Galimberti's work include Alzheimer's disease research and treatments (4 papers), Folate and B Vitamins Research (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Gloria Galimberti is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Folate and B Vitamins Research (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Gloria Galimberti collaborates with scholars based in Italy, United States and Poland. Gloria Galimberti's co-authors include Carlo Ferrarese, Gessica Sala, Valeria Isella, Ildebrando Appollonio, Maurizio Facheris, Maria Elisabetta Raggi, Nereo Bresolin, Daniela Galimberti, Serena Ghezzi and Elisa Conti and has published in prestigious journals such as PLoS ONE, Annals of Neurology and Journal of Virology.

In The Last Decade

Gloria Galimberti

15 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gloria Galimberti Italy 12 230 196 123 109 58 15 507
Michael Pirchl Austria 10 107 0.5× 150 0.8× 109 0.9× 75 0.7× 31 0.5× 13 371
Giada Mascio Italy 14 283 1.2× 242 1.2× 175 1.4× 185 1.7× 99 1.7× 28 828
Bolati Kuerban Japan 11 177 0.8× 183 0.9× 69 0.6× 70 0.6× 46 0.8× 17 405
Cristina Ordóñez Spain 15 160 0.7× 121 0.6× 87 0.7× 115 1.1× 96 1.7× 24 592
Lærke Egefjord Denmark 10 191 0.8× 331 1.7× 146 1.2× 135 1.2× 63 1.1× 10 834
Marta J. Koper Germany 8 232 1.0× 254 1.3× 113 0.9× 56 0.5× 49 0.8× 12 448
Cynthia Linares United States 4 161 0.7× 382 1.9× 173 1.4× 94 0.9× 66 1.1× 4 544
Deren Hou China 12 184 0.8× 171 0.9× 107 0.9× 65 0.6× 44 0.8× 42 503
Ana Maria Orellana Brazil 13 236 1.0× 117 0.6× 76 0.6× 119 1.1× 28 0.5× 23 536
Kevin P. Koster United States 11 236 1.0× 395 2.0× 182 1.5× 135 1.2× 49 0.8× 17 697

Countries citing papers authored by Gloria Galimberti

Since Specialization
Citations

This map shows the geographic impact of Gloria Galimberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gloria Galimberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gloria Galimberti more than expected).

Fields of papers citing papers by Gloria Galimberti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gloria Galimberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gloria Galimberti. The network helps show where Gloria Galimberti may publish in the future.

Co-authorship network of co-authors of Gloria Galimberti

This figure shows the co-authorship network connecting the top 25 collaborators of Gloria Galimberti. A scholar is included among the top collaborators of Gloria Galimberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gloria Galimberti. Gloria Galimberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lugoboni, Fabio, et al.. (2020). The FODRAT study (FOod addiction, DRugs, Alcohol and Tobacco): first data on food addiction prevalence among patients with addiction to drugs, tobacco and alcohol. Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity. 26(2). 449–455. 15 indexed citations
2.
Cinti, Alessandro, Marco De Giorgi, Elisa Chisci, et al.. (2015). Simultaneous Overexpression of Functional Human HO-1, E5NT and ENTPD1 Protects Murine Fibroblasts against TNF-α-Induced Injury In Vitro. PLoS ONE. 10(10). e0141933–e0141933. 8 indexed citations
3.
Tremolizzo, Lucio, Jacopo C. DiFrancesco, Virginia Rodriguez‐Menendez, et al.. (2012). Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 39(1). 47–51. 12 indexed citations
4.
Conti, Elisa, Gloria Galimberti, Lucio Tremolizzo, et al.. (2010). Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patients. Neuroscience Letters. 486(3). 193–196. 14 indexed citations
5.
Piazza, Fabrizio, Gloria Galimberti, Elisa Conti, et al.. (2010). Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease. Neurobiology of Aging. 33(2). 226–233. 20 indexed citations
6.
Conti, Elisa, Gloria Galimberti, Fabrizio Piazza, Maria Elisabetta Raggi, & Carlo Ferrarese. (2010). Increased Soluble APPα, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients. Alzheimer Disease & Associated Disorders. 24(1). 96–100. 24 indexed citations
7.
Cazzaniga, Emanuela, Alessandra Bulbarelli, Elena Lonati, et al.. (2008). Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients. Neuroscience Letters. 436(3). 317–320. 8 indexed citations
8.
Galimberti, Gloria, Elisa Conti, Michela Zini, et al.. (2008). Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients?. Clinical Biochemistry. 41(10-11). 914–916. 11 indexed citations
9.
Bo, Roberto Del, Marina Scarlato, Serena Ghezzi, et al.. (2005). Vascular endothelial growth factor gene variability is associated with increased risk for AD. Annals of Neurology. 57(3). 373–380. 100 indexed citations
10.
Bo, Roberto Del, Marina Scarlato, Serena Ghezzi, et al.. (2005). Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiology of Aging. 27(5). 770.e1–770.e5. 54 indexed citations
11.
Aliprandi, Angelo, Marco Longoni, Lorenzo Stanzani, et al.. (2005). Increased Plasma Glutamate in Stroke Patients Might Be Linked to Altered Platelet Release and Uptake. Journal of Cerebral Blood Flow & Metabolism. 25(4). 513–519. 52 indexed citations
12.
Facheris, Maurizio, Fulvio Magni, Gloria Galimberti, et al.. (2004). Increased Susceptibility to Plasma Lipid Peroxidation in Alzheimer Disease Patients. Current Alzheimer Research. 1(2). 103–109. 53 indexed citations
13.
Zoia, C, Tiziana Cogliati, Elena Tagliabue, et al.. (2003). Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer’s disease. Neurobiology of Aging. 25(2). 149–157. 66 indexed citations
14.
Sala, Gessica, Gloria Galimberti, Carla Canevari, et al.. (2003). Peripheral cytokine release in Alzheimer patients: correlation with disease severity. Neurobiology of Aging. 24(7). 909–914. 62 indexed citations
15.
Tocchetti, Arianna, Gloria Galimberti, Gianni Dehò, & Daniela Ghisotti. (1999). Characterization of the oriI and oriII Origins of Replication in Phage-Plasmid P4. Journal of Virology. 73(9). 7308–7316. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026